NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK

LEU vs. NXE: Which Uranium Stock is the Better Pick Now? — Positive

LEU  NXE   Zacks Investment Research — July 28, 2025

Centrus Energy boasts HALEU leadership and soaring sales; NexGen Energy holds a high-grade asset poised to reshape uranium production.

image for news LEU vs. NXE: Which Uranium Stock is the Better Pick Now?

Should You Buy, Sell or Hold CCJ Stock Before Q2 Earnings Release? — Neutral

CCJ   Zacks Investment Research — July 28, 2025

Cameco is set to post sharply higher Q2 revenues and EPS, but an earnings beat may remain out of reach.

image for news Should You Buy, Sell or Hold CCJ Stock Before Q2 Earnings Release?

Large-Cap Growth ETF (SPYG) Touches New 52-Week High — Positive

SPYG   Zacks Investment Research — July 28, 2025

SPYG hits a 52-week high as growth stocks surge on strong earnings, easing inflation and rate cut hopes.

image for news Large-Cap Growth ETF (SPYG) Touches New 52-Week High

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Many defined contribution (DC) plans remain unconvinced that members are on track for sufficient income in retirement and expect the time frame to reverse this to take decades, according to new research by leading global advisory, broking and solutions company WTW's (NASDAQ: WTW) Thinking Ahead Institute.

image for news Global DC savings still decades from resolving retirement cash crunch fears

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the “Company”)(NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

The $16 million center is managed by Community Health Development, Inc., and offers healthcare services, community support, and other resources UVALDE, Texas , July 28, 2025 /PRNewswire/ -- Superior HealthPlan and the Centene Foundation, the philanthropic arm of Centene (NYSE: CNC), today joined Community Health Development, Inc. (CHDI) to open a new $16 million multi-purpose community health center in Uvalde. The 16,000-square-foot space provides healthcare services, community support and outreach, education and workforce development, and a meeting space for the Uvalde community and the surrounding region.

image for news Superior HealthPlan and Centene Foundation Announce Grand Opening of CHDI Multi-Purpose Community Health Center in Uvalde

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. (“MarineMax” or the “Company”) (NYSE: HZO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MarineMax, Inc. – HZO

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or the “Company”)(NYSE: FI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fiserv, Inc. of Class Action Lawsuit and Upcoming Deadlines - FI

UWM Holdings: A Bet Against The Interest Rate Consensus — Positive

UWMC   Seeking Alpha — July 28, 2025

UWM Holdings Corporation is a top mortgage lender with scale advantages, high insider ownership, and a consistent, attractive 9%+ dividend yield. The company is highly leveraged to interest rates; a rate-cutting cycle would significantly boost earnings and share price. Current market pessimism is already priced in, making UWMC undervalued versus peers like Rocket, with downside risk limited by the dividend.

image for news UWM Holdings: A Bet Against The Interest Rate Consensus

Gold sells off as greenback sees sharp gains — Negative

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   Kitco — July 28, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold sells off as greenback sees sharp gains

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. (“Barnes & Noble” or the “Company”) (NYSE: BNED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Barnes & Noble Education, Inc. - BNED

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dow Inc. (“Dow” or the “Company”) (NYSE: DOW). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dow Inc. – DOW

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST

Cutting Costs Key for UPS Turnaround, Dividend in Crosshairs — Negative

UPS   Schwab Network — July 28, 2025

Marley Kayden says "to say expectations are low is fair" for UPS Inc. (UPS), however, you may not want to count the stock out. While UPS faces tariff pricing pressures and a cut to its dividend, Marley points the company's aggressive cost cutting measures as a way to balance losses.

image for news Cutting Costs Key for UPS Turnaround, Dividend in Crosshairs

Bitcoin Depot Rides on Kiosk Expansion: Bullish on Bitcoin Potential? — Positive

BTM   Zacks Investment Research — July 28, 2025

BTM rides a 228% share surge as it scales kiosk expansion, crypto deals and Bitcoin holdings to fuel growth.

image for news Bitcoin Depot Rides on Kiosk Expansion: Bullish on Bitcoin Potential?

CCL vs. NCLH: Which Cruise Stock is the Better Buy Now? — Positive

CCL  NCLH   Zacks Investment Research — July 28, 2025

Carnival rides on strong bookings, margin gains and earnings momentum, while Norwegian Cruise trails with softer growth and cost pressures.

image for news CCL vs. NCLH: Which Cruise Stock is the Better Buy Now?

Carter's Q2 Results Were Not Good, And Tariffs' Impact Is Still Incoming — Neutral

CRI   Seeking Alpha — July 28, 2025

Carter's posted positive comp sales and unit growth, signaling market share gains despite a declining US baby population. Profitability sharply deteriorated, with adjusted operating income down 75% and GAAP profits nearly breakeven due to price cuts, off-price sales, and rising SG&A. Upcoming tariffs pose major cost headwinds, and planned price increases may not be fully absorbed by consumers, risking further volume and profit declines.

image for news Carter's Q2 Results Were Not Good, And Tariffs' Impact Is Still Incoming

LOS ANGELES , July 28, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws. Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.

image for news SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT